日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma

新型 CYP2E1 抑制剂 12-咪唑基-1-十二醇有望成为治疗肝细胞癌的潜在药物

Torsten Diesinger, Alfred Lautwein, Sebastian Bergler, Dominik Buckert, Christian Renz, Radovan Dvorsky, Vyacheslav Buko, Siarhei Kirko, Edith Schneider, Florian Kuchenbauer, Mukesh Kumar, Cagatay Günes, Felicitas Genze, Berthold Büchele, Thomas Simmet, Martin Haslbeck, Kai Masur, Thomas Barth, Diet

Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness

TBX3通过增加血管生成和激活素/淋巴结依赖性干细胞诱导来促进胰腺癌的生长

Lukas Perkhofer, Karolin Walter, Ivan G Costa, Maria C Romero Carrasco, Tim Eiseler, Susanne Hafner, Felicitas Genze, Martin Zenke, Wendy Bergmann, Anett Illing, Meike Hohwieler, Ralf Köhntop, Qiong Lin, Karl-Heinz Holzmann, Thomas Seufferlein, Martin Wagner, Stefan Liebau, Patrick C Hermann, Alexan

A time frame permissive for Protein Kinase D2 activity to direct angiogenesis in mouse embryonic stem cells

允许蛋白激酶 D2 活性指导小鼠胚胎干细胞血管生成的时间框架

Martin Müller, Jana Schröer, Ninel Azoitei, Tim Eiseler, Wendy Bergmann, Ralf Köhntop, Qiong Lin, Ivan G Costa, Martin Zenke, Felicitas Genze, Clair Weidgang, Thomas Seufferlein, Stefan Liebau, Alexander Kleger

HSP90 supports tumor growth and angiogenesis through PRKD2 protein stabilization

HSP90 通过 PRKD2 蛋白稳定支持肿瘤生长和血管生成

Ninel Azoitei, Kristina Diepold, Cornelia Brunner, Arefeh Rouhi, Felicitas Genze, Alexander Becher, Hans Kestler, Johan van Lint, Gabriela Chiosis, John Koren 3rd, Stefan Fröhling, Claudia Scholl, Thomas Seufferlein

Stilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cells

二苯乙烯诱导的雄激素受体二聚化抑制:对人类前列腺癌细胞中 AR 和 ARΔLBD 信号传导的影响

Wolfgang Streicher, Manuel Luedeke, Anca Azoitei, Friedemann Zengerling, Alexander Herweg, Felicitas Genze, Mark G Schrader, Andres J Schrader, Marcus V Cronauer

Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33

HSP90 抑制剂靶向 KRAS 突变肿瘤涉及 STK33 的降解

Ninel Azoitei, Christopher M Hoffmann, Jana M Ellegast, Claudia R Ball, Kerstin Obermayer, Ulrike Gößele, Britta Koch, Katrin Faber, Felicitas Genze, Mark Schrader, Hans A Kestler, Hartmut Döhner, Gabriela Chiosis, Hanno Glimm, Stefan Fröhling, Claudia Scholl

Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation

蛋白激酶 D2 是胶质母细胞瘤生长和肿瘤形成的新型调节剂

Ninel Azoitei, Alexander Kleger, Nina Schoo, Dietmar Rudolf Thal, Cornelia Brunner, Ganesh Varma Pusapati, Alina Filatova, Felicitas Genze, Peter Möller, Til Acker, Rainer Kuefer, Johan Van Lint, Heinrich Baust, Guido Adler, Thomas Seufferlein

Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer

抑制糖原合酶激酶-3β可抵消去势抵抗性前列腺癌中雄激素受体的配体非依赖性活性

Stefanie V Schütz, Andres J Schrader, Friedemann Zengerling, Felicitas Genze, Marcus V Cronauer, Mark Schrader

Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours

蛋白激酶 D2 是胃肠道肿瘤中肿瘤细胞-内皮细胞通讯的关键调节剂

Ninel Azoitei, Ganesh Varma Pusapati, Alexander Kleger, Peter Möller, Rainer Küfer, Felicitas Genze, Martin Wagner, Johan van Lint, Peter Carmeliet, Guido Adler, Thomas Seufferlein